EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The dePARylase NUDT16 promotes radiation resistance of cancer cells by blocking SETD3 for degradation via reversing its ADP-ribosylation

Weijun Wu, Wenjing Wu, Yingshi Zhou, Qiao Yang, Shuting Zhuang, Caixia Zhong, Wenjia Li, Aixin Li, Wanzhen Zhao, Xiaomin Yin, Xuyu Zu, Carmen Chak-Lui Wong und 3 weitere

Journal of Biological Chemistry · 2024-03 · 300 (3) · 105671

DOI: 10.1016/j.jbc.2024.105671 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024-03. Verfasst von Weijun Wu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medica…. Hauptthemen laut MEDLINE: ADP-Ribosylation, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangzhou Science Technology and Innovation Commission, Science and Technology Department of Guangxi Zhuang Autonomous Region, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Poly(ADP-ribosyl)ation (PARylation) is a critical posttranslational modification that plays a vital role in maintaining genomic stability via a variety of molecular mechanisms, including activation of replication stress and the DNA damage response. The nudix hydrolase NUDT16 was recently identified as a phosphodiesterase that is responsible for removing ADP-ribose units and that plays an important role in DNA repair. However, the roles of NUDT16 in coordinating replication stress and cell cycle progression remain elusive. Here, we report that SETD3, which is a member of the SET-domain containing protein (SETD) family, is a novel substrate for NUDT16, that its protein levels fluctuate during cell cycle progression, and that its stability is strictly regulated by NUDT16-mediated dePARylation. Moreover, our data indicated that the E3 ligase CHFR is responsible for the recognition and degradation of endogenous SETD3 in a PARP1-mediated PARylation-dependent manner. Mechanistically, we revealed that SETD3 associates with BRCA2 and promotes its recruitment to stalled replication fork and DNA damage sites upon replication stress or DNA double-strand breaks, respectively. Importantly, depletion of SETD3 in NUDT16-deficient cells did not further exacerbate DNA breaks or enhance the sensitivity of cancer cells to IR exposure, suggesting that the NUDT16-SETD3 pathway may play critical roles in the induction of tolerance to radiotherapy. Collectively, these data showed that NUDT16 functions as a key upstream regulator of SETD3 protein stability by reversing the ADP-ribosylation of SETD3, and NUDT16 participates in the resolution of replication stress and facilitates HR repair.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ADP-RibosylationNeoplasmsDNA Breaks, Double-StrandedDNA DamageDNA RepairPoly (ADP-Ribose) Polymerase-1Protein Processing, Post-TranslationalHumansCell LinePyrophosphatasesHistone Methyltransferases

Stichwörter der Autor:innen

CHFRNUDT16PARylationSETD3ubiquitination

Substanzen

Poly (ADP-Ribose) Polymerase-1PyrophosphatasesHistone Methyltransferases

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen Universi…
  • Department of Oncology Radiotherapy, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
  • Department of Pathology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.
  • Cancer Research Institute, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
  • Li Ka Shing Faculty of Medicine, Department of Pathology, The University of Hong Kong, Hong Kong, Guangdong, China.
  • Department of Oncology Radiotherapy, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China. Electronic address: 2018012078@usc.edu.cn.

Förderung

  • Guangzhou Science Technology and Innovation Commission
  • Science and Technology Department of Guangxi Zhuang Autonomous Region
  • National Key Research and Development Program of China
  • Natural Science Foundation of Hunan Province
  • Guangzhou Municipal Science and Technology Project
  • National Natural Science Foundation of China
  • Sun Yat-sen University
  • Natural Science Foundation of Guangdong Province

Zitieren

APA

Wu, W., Wu, W., Zhou, Y., Yang, Q., Zhuang, S., Zhong, C., Li, W., Li, A., Zhao, W., Yin, X., Zu, X., Chak-Lui Wong, C., Yin, D., Hu, K., & Cai, M. (2024). The dePARylase NUDT16 promotes radiation resistance of cancer cells by blocking SETD3 for degradation via reversing its ADP-ribosylation. Journal of Biological Chemistry, 300(3), 105671. https://doi.org/10.1016/j.jbc.2024.105671

Vancouver

Wu W, Wu W, Zhou Y, Yang Q, Zhuang S, Zhong C, et al. The dePARylase NUDT16 promotes radiation resistance of cancer cells by blocking SETD3 for degradation via reversing its ADP-ribosylation. Journal of Biological Chemistry. 2024;300(3):105671. doi:10.1016/j.jbc.2024.105671

BibTeX
@article{Wu2024,
  author = {Wu, Weijun and Wu, Wenjing and Zhou, Yingshi and Yang, Qiao and Zhuang, Shuting and Zhong, Caixia and Li, Wenjia and Li, Aixin and Zhao, Wanzhen and Yin, Xiaomin and Zu, Xuyu and Chak-Lui Wong, Carmen and Yin, Dong and Hu, Kaishun and Cai, Manbo},
  title = {The dePARylase NUDT16 promotes radiation resistance of cancer cells by blocking SETD3 for degradation via reversing its ADP-ribosylation},
  journal = {Journal of Biological Chemistry},
  year = {2024},
  volume = {300},
  number = {3},
  pages = {105671},
  doi = {10.1016/j.jbc.2024.105671}
}
Kostenlos starten →